[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-232221-105":59,"doc-detail-232221-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ptn-post-january-2013-issue-4","PTN Post - January 2013 - Issue 4","","PTN Post January 2013 Issue 4 recaps key accomplishments from 2012 for the Pediatric Trials Network, including finalized protocols, enrolled and completed pediatric trials, and submission of a first clinical study report to the FDA. The issue highlights the renewal of pediatric legislation enabling this work and recognizes the dedication of PTN core chairs, protocol chairs, and leading enrollers across participating sites. It concludes with an outlook for continued collaboration in 2013.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ptn-post-january-2013-issue-4/232221/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ptn-post-january-2013-issue-4/232221.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-17","2026-09-10",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What major accomplishments are highlighted for 2012 in PTN Post Issue 4?","Question",{"text":113,"@type":114},"The issue notes three finalized protocols, six trials enrolling over 1,100 patients, three trials completing enrollment and moving into analysis, and submission of a first clinical study report (metronidazole) to the FDA.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why does the Pediatric Trials Network emphasize pediatric legislation in this issue?",{"text":118,"@type":114},"It references the renewal of pediatric legislation that makes PTN’s work possible, supporting studies of drugs in children.",{"name":120,"@type":111,"acceptedAnswer":121},"Who is recognized in this issue of PTN Post for helping make 2012 successful?",{"text":122,"@type":114},"The issue thanks PTN individuals including core chairs, protocol chairs, and leading enrollers, along with investigators and site personnel across multiple PTN locations.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},232221,1789069900,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":130,"read_time":52,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","POST JANuAry2013 • ISSue 4  \nHappy New Year to Our PTN Sites and Investigators  \nIn closing the book on 2012, I’d like to take a moment to reflect on all that we have accomplished in the past year. Three new protocols were finalized, 6 trials enrolled over 1100 patients, 3 trials  \ncompleted enrollment and are in the analysis phase, and our first clinical study report (for metronidazole) was submitted to the FDA. Additionally, 2012 saw the renewal of the pediatric legislation that makes all of this work possible . But we couldn’t have done any of it without the dedication and hard work of our sites and investigators .  \nIn this issue of the PTN Post , we tip our hats to the individuals who helped to make 2012 a terrific year for the Pediatric Trials Network. Thank you for your commitment to improving medicine for children . We look forward to continuing our collaboration in 2013.  \nSincerely,  \nDanny Benjamin, MD, PhD, MPH, Lead Principal Investigator  \nPTN core chairs  \nProtocol chairs  \nLeading enrollers for PTN trials in 2012  \nPOPS  \n| | |\n| --- | --- |\n\nAdriana Tremoulet (PI) and Pam Emery (SC) of Rady Children’s Hospital, San Diego  \nHydroxyurea  \n| | |\n| --- | --- |\n\nRobert Liem (PI), Stephanie Pelligra (SC), Lurie Children’s Hospital of Chicago  \nPTN POST • JaNuary 2013 • ISSue 4  \nLeading enrollers for PTN trials in 2012  \nTAPE  \nIan Paul (PI) and Jennifer Stokes (SC) and the Pediatric Clinical Research Office at Penn State Hershey Medical Center  \nMetronidazole  \nJames Wynn (PI)—Vanderbilt University, Kimberley Fisher and Laura Stern (SCs, not pictured), Duke University Medical Center  \nAntonio Arrieta (PI) and Ofelia Vargas-Shiraishi and Claudia Enriquez (SCs), Children’s Hospital of Orange County  \nPTN POST • JaNuary 2013 • ISSue 4  \nOther PTN sites enrolling in 2012  \nAcyclovir  \nTulaNe uNIverSITy HealTH SCIENCES CENTER:  \nEuming Chong (PI) and Jane Reynolds (SC)  \nHydroxyurea  \nMEdICAL COLLEGE Of WISCONSIN:  \nAmanda Brandow (PI) and Rebecca Farley (SC)  \nuaB-CHIldreN’S HOSPITal Of alaBama:  \nThomas Howard (PI) and Melissa Bagwell (SC)  \narkaNSaS CHIldreN’S HOSPITal:  \nShelley Crary (PI) and Dawn Hansberry (SC)  \nuNIverSITy Of TexaS  \nSOuTHweSTerN medICal CeNTer:  \nZora Rogers (PI) and Leah Adix (SC)  \n\n| The Pediatric Trials Network (PTN) is made possible by the Best Pharmaceuticals for Children Act (BPCA) . The BPCA, first enacted in 2002, provides mechanisms for studying on-and offpatent drugs in children . Visit us on the web at [www.pediatrictrials.org](www.pediatrictrials.org).\u003Cbr>The Pediatric Trials Network is supported by The eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, and U.S . Department of Health and Human Services . |  |  |\n| --- | --- | --- |\n| | |  |\n|  | | |\n| PTN POST • JaNuary 2013 • ISSue 4 |  |  |\n\nLisinopril  \nMONTEfIORE MEdICAL CENTER:  \nFrederick Kaskel (PI) and Patricia Flynn (SC)  \nCINCINNaTI CHIldreN’S HOSPITal:  \nJens Goebel (PI) and Carrie Schultz (SC)  \nCHIldreN’S merCy HOSPITal aNd CLINICS:  \nBrad Warady (PI) and Talita Hill (SC)  \nemOry uNIverSITy CHIldreN’S CENTER:  \nLaurence Greenbaum (PI) and Margo Kamel (SC)  \nNew yOrk uNIverSITy laNgONe MEdICAL CENTER:  \nHoward Trachtman (PI) and Suzanne Vento (SC)  \nuaB-CHIldreN’S HOSPITal Of alaBama:  \nDaniel Feig (PI) and Stephanie Clevenger (SC)  \narkaNSaS CHIldreN’S HOSPITal:  \nEileen Ellis (PI) and Lee Howard (SC)  \nuNIverSITy Of mICHIgaN HealTH SYSTEM:  \nDebbie Gipson (PI) and Jennifer Mawby (SC)  \nPOPS  \naxIS ClINICal TrIalS:  \nLydie Hazan (PI) and Angelica Covarrubias (SC)  \nakrON CHIldreN’S HOSPITal:  \nMichael Reed (PI) and Tonia Polanski (SC)  \nCHIldreN’S merCy HOSPITal aNd CLINICS:  \nKathleen Neville (PI) and Jaylene Weigel (SC)  \nCHIldreN’S NaTIONal medICal CENTER:  \nJohn van den Anker (PI) and Elaine Williams (SC)  \nmedICal uNIverSITy Of SOuTH CAROLINA:  \nAndrew Atz (PI), Patricia Infinger (SC), and Charles Bryant (SC)  \narkaNSaS CHIldreN’S HOSPITal:  \nLaura James ","cbCailb5jPILVv2x","https://ap.wps.com/l/cbCailb5jPILVv2x","pdf",1012247,"English","# Happy New Year to Our PTN Sites and Investigators\n## 2012 Accomplishments and Key Activities\n## Recognized PTN Contributors and Enrolling Sites","[{\"question\":\"What major accomplishments are highlighted for 2012 in PTN Post Issue 4?\",\"answer\":\"The issue notes three finalized protocols, six trials enrolling over 1,100 patients, three trials completing enrollment and moving into analysis, and submission of a first clinical study report (metronidazole) to the FDA.\"},{\"question\":\"Why does the Pediatric Trials Network emphasize pediatric legislation in this issue?\",\"answer\":\"It references the renewal of pediatric legislation that makes PTN’s work possible, supporting studies of drugs in children.\"},{\"question\":\"Who is recognized in this issue of PTN Post for helping make 2012 successful?\",\"answer\":\"The issue thanks PTN individuals including core chairs, protocol chairs, and leading enrollers, along with investigators and site personnel across multiple PTN locations.\"}]","PTN Post - January 2013 - Issue 4 | PDF"]